- Fast Track designation indicates CBL-514's potential in filling the unmet medical need of Dercum's disease. - CBL-514 is the first drug to receive Fast Track designation for Dercum's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback